China wants to patent Gilead’s experimental coronavirus drug

The Wuhan Institute of Virology has applied for a patent in China for the use of Gilead's antiviral drug, known as remdesivir, in treating the ailment. - AFP

BEIJING (Bloomberg): Chinese researchers have applied for a local patent on an experimental Gilead Sciences Inc drug that they believe might fight the novel coronavirus outbreak.

The Wuhan Institute of Virology -- based in the central Chinese city at the epicentRE of the epidemic -- has applied for a patent in China for the use of the antiviral drug, know as remdesivir, in treating the ailment.